The NHS will roll out a new treatment for advanced bladder cancer which doubles survival time. It's estimated that 1,250 ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

A new treatment for advanced bladder cancer which doubles survival time has been given the green light for NHS use.

MDMA (Molly, ecstasy) is an empathogen widely used as a club drug that may become a future treatment for PTSD. Many respond ...

Tech rout led to another session of weakness on Wall Street on Tuesday as heavily-weighted Nvidia (NVA), peer AMD (AMD), and ...

The AI-enabled bundled system used sensors and coaching to guide patients. It generated personalized recommendations by ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

Recent advancements in Merck's (MRK) product portfolio, including the FDA's Breakthrough Therapy Designation for ifinatamab deruxtecan and several approvals of their flagship drug KEYTRUDA, are ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech', HKEX: 6990) announced that clinical data from a Phase II study evaluating novel TROP2 antibody-drug conjugate (ADC) sacituzumab ...

Merck has partnered with company builder mantro GmbH to launch EdiMembre, a deep-tech spinout that will commercialize Merck's ...